United States HRES 1125: Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.

Status: Introduced in House (as of 2020-09-18)

State: United States · Session: 116 · Bill: HRES 1125

Subjects: Cardiovascular and respiratory health, Community life and organization, Emergency medical services and trauma care, Health care coverage and access, Health programs administration and funding, Immunology and vaccination, Infectious and parasitic diseases, Medical research, Medical tests and diagnostic methods, Minority health, Research administration and funding

Sponsors: ELIOT L. ENGEL, Adriano Espaillat, Albio Sires, Ami Bera, BARBARA LEE, DAVID E. PRICE, David J. Trone, Donald M. Payne, EDDIE BERNICE JOHNSON, ELEANOR HOLMES NORTON, Elaine G. Luria, GREGORY W. MEEKS, Gilbert Ray Cisneros, JAMES P. MCGOVERN, JERROLD NADLER, Jahana Hayes, Joaquin Castro, Judy Chu, Michael F. Q. San Nicolas, Nanette Diaz Barragan, SHEILA JACKSON LEE, Steve Cohen, Terri A. Sewell

View United States HRES 1125 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.